JB Chemicals & Pharmaceuticals has announced the resignation of its Executive Vice President, Jason D’souza, effective from the close of business on 6 March 2026.
The company disclosed that the resignation of Mr. D’souza was due to personal reasons. The announcement was delayed unintentionally, as noted in the communication to the stock exchanges. The company has now complied with the necessary disclosure requirements under the Securities and Exchange Board of India regulations.
Disclaimer: This article is based on a regulatory filing submitted to the National Stock Exchange of India (NSE).